Yale-New Haven Hospital (YNHH) is a tertiary care hospital in the Yale-New Haven Health System. YNHH centers of excellence include oncology, pediatrics, pulmonology, cardiology, and women's health. YNHH serves as the primary teaching site for Yale University Schools of Medicine and Nursing. New Haven is located on the shoreline of Connecticut (Long Island Sound), a two hour drive from New York City and Boston. Located in scenic New England, Yale-New Haven Hospital is spread out on 2 campuses within walking distance of each other. The Pharmacy Department that serves both campuses is progressive, providing decentralized clinical services, automation, USP 797 sterile preparation, and support to numerous ambulatory clinics and a 125-bed skilled nursing facility.
*Please note that position availability may be updated following the early commitment process.*
PGY2 ONCOLOGY (3 positions):
As part of twelve disease teams, the PGY2 oncology resident will focus on medication therapy management for oncology, hematology, and bone marrow transplant patients in the inpatient and outpatient settings. The resident’s research exposure includes Phase I, cooperative group, precision medicine, and investigator initiated studies. Teaching opportunities include clinical teaching of PharmD students and PGY-1 residents with didactic lecture opportunities available. Multiple electives allow the resident to tailor learning to their interests and career goals.
PGY2 INVESTIGATIONAL DRUGS AND RESEARCH (1 position):
Our PGY 2 Investigational Drugs and Research pharmacy residency program builds on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical research pharmacists. The residency program is designed to develop skilled clinical research pharmacists who provide exceptional pharmaceutical care to research patients, and are leaders who can manage ever-changing landscape of research pharmacy. It also provides opportunities to collaborate with world-renowned researchers.
Core rotations include: IDS operations, IDS cancer care centers, IDS regulatory compliance, IDS leadership and management, and research patient care. Multiple electives allow the resident to tailor learning to their interests, with ~ 50% of learning experiences focused on oncology practice settings, and others provide experience to critical care and ambulatory care settings. Completion of the residency program will prepare pharmacists for specialized career in clinical research, with opportunities in hospital, industry, and regulatory agencies.
ONCOLOGY JOBS (2 positions):
Manager, Clinical Pharmacy Oncology Smilow Cancer Center:
https://jobs.ynhhs.org/jobs/4535646-manager-clinical-pharmacy-oncology-smilow-cancer-center
Clinical Pharmacist, Oncology Smilow Cancer Center:
https://jobs.ynhhs.org/jobs/4644541-clinical-oncology-pharmacist
